Control of cell cycle checkpoint mediated by mammalian target of rapamycin
雷帕霉素哺乳动物靶标介导的细胞周期检查点的控制
基本信息
- 批准号:10680609
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Rapamycin is a lipophilic macrolide compound and binds to FKBP12 in mammalian cells. The mTOR (mammalian target of rapamycin) protein was identified as a target of FKBP12-rapamycin complex. This protein has a calculated molecular weight of 289 kDa and contains a kinase-like domain at its carboxyl-terminus. In this study, we obtained following findings.(1)mTOR participates in nutrient-sensing, especially amino acid-sensing, in mammalian cells and regulates translational effectors, such as p70S6 kinase α (p70α) and eIF4E binding protein (4EBP).(2)Activation of amino acid-mTOR signaling pathway is indispensable for mitogen-induced protein synthesis. In other words, amino acid-mTOR signaling is a priming signal for mitogen-induced protein synthesis.(3)Among amino acids, leucine has the most potent ability to activate phosphorylation of p70α.(4)p70α, extracted in inactive forms from rapamycin-treated cells, can be directly phosphorylated by the mTOR kinase at the rapamycin-sensitive site Thr-412. mTOR-catalyzed p70α phosphorylation in vitro is accompanied by a substantial restoration in p70α kinase activity.(5)Sequential phosphorylation of p70α by mTOR and 3-phosphoinositide-dependent protein kinase 1 in vitro results in a synergistic stimulation of p70α activity to levels similar to that attained by serum stimulation in vivo.(6)Several candidates of binding partners of mTOR were identified using conventional biochemical methods and yeast-two hybrid system and detailed analyses are now in progress.(7)Some of leucine derivatives were found to have the ability to inhibit p70α activation and T cell proliferation. This analysis is also now in progress.
雷帕霉素是一种亲脂性大环内化合物,与哺乳动物细胞中的FKBP12结合。 MTOR(雷帕霉素的哺乳动物靶标)蛋白被鉴定为FKBP12-宽霉素复合物的靶标。该蛋白质的分子量为289 kDa,并在其羧基末端包含一个类似激酶的结构域。在这项研究中,我们获得了遵循发现。(1)MTOR参与哺乳动物细胞中的营养 - 氨基酸 - 氨基酸 - 敏感性,并调节翻译作用,例如p70s6激酶α(p70α)(p70α)和eIF4E EIF4E结合蛋白(4EEBP)(4EEBP)。 other words, amino acid-mTOR signaling is a priming signal for mitogen-induced protein synthesis.(3)Among amino acids, leucine has the most potential ability to activate phosphorylation of p70α.(4)p70α, extracted in active forms from rapamycin-treated cells, can be directly phosphorylated by the mTOR kinase at the rapamycin-sensitive site Thr-412. MTOR催化的p70α磷酸化体外伴随着p70α激酶活性中的二次恢复。(5)MTOR对p70α的顺序磷酸化,MTOR和3-磷酸固醇依赖性的蛋白依赖性蛋白激酶1中的几个刺激在Viv刺激中,在Viv刺激中,在Viv刺激中,在Viv刺激中相似。使用常规的生化方法和酵母 - 两种混合动力系统鉴定了MTOR结合伙伴的候选者,现在正在进行详细的分析。(7)发现某些亮氨酸衍生物具有抑制p70α激活和T细胞增殖的能力。该分析也正在进行中。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nanahoshi, M.: "Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42"Biochem. Biophys. Res. Commun.. 251. 520-526 (1998)
Nanahoshi, M.:“α4 蛋白及其酵母同源物 Tap42 对蛋白磷酸酶 2A 催化活性的调节”Biochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shigemitsu K.: "Structural requirement of leucine for activation of p70 S6 kinase"FEBS Let.. 447・2-3. 303-306 (1999)
K重光:“p70 S6激酶激活的亮氨酸的结构要求”FEBS Let.. 447・2-3 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Gout, I.: "Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase β containing a proline-rich domain"J. Biol. Chem.. 273. 30061-30064 (1998)
Gout, I.:“新型 p70 S6 激酶(含有富含脯氨酸结构域的 p70 S6 激酶 β)的分子克隆和表征”J. Biol. 273. 30061-30064 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shigemitsu, K.: "Structural requirement of leucine for activation of p70 S6 kinase"FEBS Let.. 447. 303-306 (1999)
Shigemitsu, K.:“亮氨酸激活 p70 S6 激酶的结构要求”FEBS Let.. 447. 303-306 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishimura, T.: "Characterization of he phosphoproteins and protein kinase activity in mTOR immunoprecipitates"Biochem. Biophys. Res. Commun.. 252. 440-444 (1998)
Nishimura, T.:“mTOR 免疫沉淀中磷蛋白和蛋白激酶活性的表征”Biochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YONEZAWA Kazuyoshi其他文献
YONEZAWA Kazuyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YONEZAWA Kazuyoshi', 18)}}的其他基金
Studies on molecular mechanism of mTOR signaling that controls various cellular functions in response to amino acid sufficiency.
研究 mTOR 信号传导的分子机制,该信号传导响应氨基酸充足而控制各种细胞功能。
- 批准号:
13680714 - 财政年份:2001
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on molecular mechanism of mTOR signaling that controls protein synthesis, cell growth, and cell cycle in response to amino acid sufficiency
研究 mTOR 信号传导响应氨基酸充足性而控制蛋白质合成、细胞生长和细胞周期的分子机制
- 批准号:
12480190 - 财政年份:2000
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
亮氨酸-tRNA合成酶LARS促进LRPPRC蛋白合成调控骨肉瘤恶性行为的分子机制研究
- 批准号:82372668
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
富含亮氨酸跨膜纤连蛋白FLRT2上调EPSTI1促进内皮炎症致动脉粥样硬化的机制研究
- 批准号:82370462
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
大丽轮枝菌富含亮氨酸结构蛋白VdLRR1与葡聚糖水解酶VdSUN4互作协同调控分生孢子形成的机制
- 批准号:32372499
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
LIGHT/HVEM-亮氨酸轴异常引起蜕膜基质细胞过度衰老致复发流产的机制研究
- 批准号:32370914
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
痂疮链霉菌毒力因子莎斯托明和冠法酰异亮氨酸交叉调控的机制研究
- 批准号:32370077
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Brainstem nutrient sensing in the integrative control of food intake
脑干营养传感在食物摄入综合控制中的应用
- 批准号:
8876024 - 财政年份:2015
- 资助金额:
$ 2.11万 - 项目类别:
Signaling Cascades in Regulation of Pancreatic Beta cell mass.
胰腺β细胞团调节中的信号级联。
- 批准号:
8003286 - 财政年份:2010
- 资助金额:
$ 2.11万 - 项目类别:
Signaling Cascades in Regulation of Pancreatic Beta cell mass.
胰腺β细胞团调节中的信号级联。
- 批准号:
7564673 - 财政年份:2008
- 资助金额:
$ 2.11万 - 项目类别: